×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Gian Life Care Limited | NA | NA | NA | NA | 15.3 | 170.0 |
| Parmax Pharma Limited | NA | NA | NA | NA | 14.5 | |
| Span Divergent Limited | NA | NA | NA | NA | 12.7 | 15.9 |
Gian Life Care Limited, with Security Code 542918, is a leading player in the Healthcare Service Provider industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 8.6 | 5.3 | 5.1 | 1.5 | 2.4 | 2.3 | 3.8 | 4.6 | 2.0 | 1.9 |
| Expenses | 6.2 | 4.8 | 2.8 | 2.3 | 1.9 | 2.0 | 1.6 | 1.5 | 1.8 | 1.7 |
| Operating Profit | 2.4 | 0.4 | 2.3 | -0.7 | 0.5 | 0.3 | 2.2 | 3.1 | 0.2 | 0.2 |
| OPM % | 28.21% | 8.43% | 45.01% | -46.48% | 21.08% | 14.27% | 59.09% | 67.43% | 11.3% | 11.45% |
| Other Income | 0.4 | 0.3 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | 2.4 | 0.4 | 2.2 | -0.8 | 0.4 | 0.2 | 2.2 | 3.1 | 0.2 | 0.2 |
| Tax % | -25.4% | -25.3% | -13.9% | 17.2% | -34.7% | -15.3% | -24.6% | -29.2% | -35.8% | -15.5% |
| Net Profit | 1.8 | 0.3 | 1.9 | -0.9 | 0.3 | 0.2 | 1.6 | 2.2 | 0.1 | 0.1 |
| EPS in Rs | 1.7 | 0.26 | 1.83 | -0.87 | 0.26 | 0.2 | 1.57 | 2.13 | 0.1 | 0.14 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.1 | 1.5 | 2.4 | 2.3 | 3.8 | 4.6 | 2.0 | 1.9 | 1.6 |
| Expenses | 2.8 | 2.3 | 1.9 | 2.0 | 1.6 | 1.6 | 1.8 | 1.7 | 1.1 |
| Operating Profit | 2.3 | -0.8 | 0.5 | 0.3 | 2.2 | 3.0 | 0.2 | 0.2 | 0.5 |
| OPM % | 44.53% | -49.58% | 21% | 14.23% | 57.82% | 66.16% | 11.15% | 11.4% | 33.48% |
| Other Income | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 |
| Interest | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
| Depreciation | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 |
| Profit before tax | 2.2 | -0.8 | 0.4 | 0.2 | 2.1 | 3.0 | 0.2 | 0.1 | 0.4 |
| Tax % | -14.1% | 16.1% | -34.8% | -15.4% | -25.5% | -29.4% | -39.1% | -18.2% | 0% |
| Net Profit | 1.9 | -1.0 | 0.3 | 0.2 | 1.6 | 2.1 | 0.1 | 0.1 | 0.4 |
| EPS in Rs | 1.8 | -0.92 | 0.25 | 0.2 | 1.5 | 2.07 | 0.09 | 0.12 | 0.34 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 87% |
| 3 Years: | 8% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 112% |
| 3 Years: | 29% |
| TTM: | 181% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | -5% |
| 1 Year: | -14% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| TTM: | 184% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | -5% |
| 1 Year: | -14% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|